CoChat

Minimization of Immunosuppressive Therapy After Renal Transplantation: Results of a Randomized Controlled Trial

Open access
Vanrenterghem, Yves, van Hooff, Johannes P., Squifflet, Jean-Paul, Salmela, Kaija, Rigotti, Paolo, Jindal, Rahul M., Pascual, Julio, Ekbergh, Henrik, Sicilia, Luis Sanchez, Boletis, John N., Grinyo, Josep M., Rodriguez, Manuel Arias · 2005 · American Journal of Transplantation
Cited by 149

The DOI matches its Crossref record.

Abstract

Modern immunosuppressive regimens reduce the acute rejection rate by combining a cornerstone immunosuppressant like tacrolimus or cyclosporine with adjunctive agents like corticosteroids, mycophenolate mofetil (MMF) or azathioprine, often associated with untoward side effects. A 6-month randomized study was conducted in 47 European centers. Triple therapy with tacrolimus (trough levels 5-15 ng/mL), corticosteroids (dosage 10 mg/day) and MMF (1 g/day) was administered for 3 months. From day 92, patients either continued with triple therapy (control, n = 277), or stopped steroids (n = 279), or stopped MMF (n = 277). Surrogate markers for long-term benefits were changes in lipid profiles and occurrence of hematological, gastrointestinal and infectious complications. The 6-month acute rejection incidence (biopsy-proven) was similar in all groups (17.0% vs. 15.1% vs. 14.8%, p = 0.744), although the incidence after month 3 was higher in the steroid stop group than in the two other groups. Mean reductions in total cholesterol (18.9 mg/dL [0.49 mmol/L]) and LDL-cholesterol (8.1 mg/dL [0.21 mmol/L]) between months 4 and 6 were greater in the steroid stop group (p < 0.001). Leukopenia (p = 0.0082), serious CMV infection (p = 0.024), anemia (p = NS) and diarrhea (p = NS) were less frequent in the MMF stop group. In a study population of immunologically low-risk patients' withdrawal of corticosteroids or MMF from a tacrolimus-based therapy at 3 months was feasible. A longer follow-up will be needed to confirm the expected advantages for the long-term outcome and to assess the long-term safety of this minimization of immunosuppressive therapy.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1600-6143.2004.00638.x

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 149

Metadata

Authors
Vanrenterghem, Y., van Hooff, J. P., Squifflet, J.-P., Salmela, K., Rigotti, P., Jindal, R. M., Pascual, J., Ekbergh, H., Sicilia, L. S., Boletis, J. N., Grinyo, J. M., & Rodriguez, M. A.
Venue
American Journal of Transplantation
Publisher
Elsevier BV
Published
2005-01
Volume
5
Issue
1
Pages
87-95
ISSN
1600-6135 (ISSN-L)
OpenAlex
W2018384104
Cited by
149
References
0
FWCI
9.77
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Minimization of Immunosuppressive Therapy After Renal Transplantation: Results of a Randomized Controlled Trial. https://app.cochat.ai/papers/10.1111/j.1600-6143.2004.00638.x
The paper
Vanrenterghem, Y., van Hooff, J. P., Squifflet, J.-P., Salmela, K., Rigotti, P., Jindal, R. M., Pascual, J., Ekbergh, H., Sicilia, L. S., Boletis, J. N., Grinyo, J. M., & Rodriguez, M. A. (2005). Minimization of Immunosuppressive Therapy After Renal Transplantation: Results of a Randomized Controlled Trial. American Journal of Transplantation. https://doi.org/10.1111/j.1600-6143.2004.00638.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.